Trimetazidine to reverse ischemia in patients with class I or II angina: A randomized, double-blind, placebo-controlled dobutamine-atropine stress echocardiography study

Coronary Artery Disease

Volumn 18, Issue 4, 2007, Pages 259-263

  Cesar, Luiz A M ^a   Mathias Jr , Wilson ^a   Armaganijan, Dikran ^b   Gimenez, Vera ^b   Jallad, Sergio ^a   Del Monaco, Maria Izabel ^b   Bicudo, Letícia ^a   Meneguin, Silmara ^a   Gomes, Everli P ^a   Brasil, Clarisse K ^b   Ramires, Jose F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

Author keywords

Angina pectoris; Coronary heart disease; Ischemia; Stress echocardiography

Indexed keywords

ATROPINE; DOBUTAMINE; PLACEBO; TRIMETAZIDINE;

ADULT; ANGINA PECTORIS; ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FAILURE; HEART VENTRICLE WALL; HEART VENTRICLE WALL MOTION; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STRESS ECHOCARDIOGRAPHY;

AGED; ANGINA PECTORIS; ATROPINE; DOBUTAMINE; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY, STRESS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; TREATMENT OUTCOME; TRIMETAZIDINE; VASODILATOR AGENTS;

EID: 34248325231     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e3280d5a7d0     Document Type: Article

References (12)

1. Carroll K, Majeed A, Firth C, Gray J. Prevalence and management of coronary heart disease in primary care: population-based cross-sectional study using a disease register. J Public Health Med 2003; 25:29-35.
2. Chaitman BR, Pepine CJ, Parker JO, Skopal J, Chumakova G, Kuch J, et al. Combination assessment of ranolazine in stable angina (CARISA) investigators. JAMA 2004; 291:309-316.
3. Detry JM, Leclercq PJ. Trimetazidine European multicenter study versus propranolol in stable angina pectoris: contribution of Holter electrocardiographic ambulatory monitoring. Am J Cardiol 1995; 76:8B-11B.
4. Lu C, Dabrowski P, Fragasso G, Chierchia SL. Effects of trimetazidine on ischemic left ventricular dysfunction in patients with coronary artery disease. Am J Cardiol 1998; 82:898-901.
5. Belardinelli R, Purcaro A. Effects of trimetazidine on the contractile response of chronically dysfunctional myocardium to low-dose dobutamine in ischaemic cardiomyopathy. Eur Heart J 2001; 22:2164-2170.
6. Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on management of patients with chronic stable angina). J Am Coll Cardiol 1999; 33:2092-2197.
7. Campeau L. Grading of angina pectoris [letter]. Circulation 1976; 54:522-523.
8. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Exercise cross-sectional echocardiography in ischemic heart disease. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography committee on standards, subcommittee on quantitation of twodimensional echocardiograms. J Am Soc Echocardiogr 1989; 2:358-367.
9. Mathias WJr, Tsutsui JM, Andrade JL, Kowatsch I, Lemos PA, Leal SM, et al. Value of rapid beta-blocker injection at peak dobutamine-atropine stress echocardiography for detection of coronary artery disease. J Am Coll Cardiol 2003; 41:1583-1589.
10. Armstrong WF, Pellikka PA, Ryan T, Crouse L, Zoghbi WA. Stress echocardiography: recommendations for performance and interpretation of stress echocardiography. Stress echocardiography task force of the nomenclature and standards committee of the American Society of Echocardiography. J Am Soc Echocardiogr 1998; 11:97-104.
11. Fragasso G, Piatti Md PM, Monti L, Palloshi A, Setola E, Puccetti P, et al. Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy. Am Heart J 2003; 146:E1-E8.
12. Thrainsdottir IS, von Bibra H, Malmberg K, Ryden L. Effects of trimetazidine on left ventricular function in patients with type 2 diabetes and heart failure. J Cardiovasc Pharmacol 2004; 44:101-108.